Orthopaedics and Sports Medicine, Seattle Children's Hospital, 4800 Sandpoint Way NE, Seattle, WA 98105, USA.
Skeletal Radiol. 2012 May;41(5):607-10. doi: 10.1007/s00256-011-1261-9. Epub 2011 Sep 4.
Metachondromatosis (MC) and hereditary multiple osteochondromas (HMO) are thought to be distinct disorders, each with characteristic x-ray and clinical features. Radiographic differences are the current mainstay of differential diagnosis. Both disorders are autosomal dominant, but the majority of patients with HMO have mutations in EXT-1 or EXT 2 genes. The genetic defect in MC is unknown, although recent studies indicate a possible identifiable mutation. The cancer risk in HMO is thought to be greater than in MC, although the small number of cases make such conjecture imprecise. The purpose of this report is to review existing literature and examine whether radiographic findings in HMO and MC can be reliable as a stand-alone means of differential diagnosis. Three members of a multi-generational family with an autosomal dominant exostosis syndrome were studied by clinical examination and complete skeletal survey. The roentgenographic characteristics of all osteochondromas were analyzed. The father underwent gene sequencing for EXT-1 and EXT-2, which revealed a novel EXT-2 mutation. Typical radiographic and clinical findings of both HMO and MC were seen throughout the family as well as in individuals. These family study findings contradict many of the long-standing clinical and x-ray diagnostic criteria for differentiating MC from HMO. The phenotypic crossover between the two conditions in this family, and results of genetic analysis, suggest that in the absence of a definitive genetic diagnosis, radiographic and clinical diagnosis of past and future cases HMO and MC may not be as reliable as previously assumed.
多发性外生性骨软骨瘤病(MC)和遗传性多发性骨软骨瘤(HMO)被认为是两种不同的疾病,每种疾病都有其特征性的 X 射线和临床特征。放射学差异是目前鉴别诊断的主要依据。这两种疾病都是常染色体显性遗传,但大多数 HMO 患者的 EXT-1 或 EXT2 基因都有突变。MC 的遗传缺陷尚不清楚,尽管最近的研究表明可能存在可识别的突变。HMO 的癌症风险被认为大于 MC,尽管病例数量较少,使得这种推测不够准确。本报告的目的是回顾现有文献,探讨 HMO 和 MC 的放射学表现是否可以作为可靠的独立鉴别诊断手段。对一个三代同堂的常染色体显性外生骨疣综合征家族的 3 名成员进行了临床检查和全面骨骼检查。分析了所有骨软骨瘤的 X 射线特征。父亲接受了 EXT-1 和 EXT-2 的基因测序,结果显示 EXT-2 有一个新的突变。整个家族以及个体中均可见到典型的 HMO 和 MC 的放射学和临床特征。这些家族研究结果与长期以来区分 MC 和 HMO 的临床和 X 射线诊断标准相矛盾。两种情况下的表型交叉以及遗传分析的结果表明,在没有明确的遗传诊断的情况下,过去和未来 HMO 和 MC 病例的放射学和临床诊断可能不如以前假设的那样可靠。